4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-113538
Chief Medical Officer sold 4,425 shares at an average $13.30 ($58,842)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kerr Douglas Chief Medical Officer | 2025-09-04 | Sale 10b5-1 | −3,552 | $13.27 | $47,135 | 89,263 | D |
| Kerr Douglas Chief Medical Officer | 2025-09-05 | Sale 10b5-1 | −873 | $13.41 | $11,707 | 88,390 | D |
| Open-market sales · 4,425 sh · avg $13.30 · $58,842 | |||||||
Loading xslF345X05/ownership.xml…